Bone substitutes as carriers for transforming growth factor-β1 (TGF-β1)

International Orthopaedics

Volumn 26, Issue 4, 2002, Pages 203-206

  Gille, Justus ^a   Dorn, B ^c   Kekow, J ^b   Bruns, J ^c   Behrens, P ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Vogelsang Hospital   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN SERUM ALBUMIN; HYDROXYAPATITE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BONE PROSTHESIS; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; KINETICS; MEASUREMENT; PRIORITY JOURNAL;

EID: 0036943513     PISSN: 03412695     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00264-002-0353-5     Document Type: Article

References (28)

1. Baylink DJ, Finkelmann RD, Mohan S (1993) Growth factors to stimulate bone formation. J Bone Miner Res 8: 565-572
2. Behrens P, Doden E, Hassenpflug J, Baylink DJ (1992) Development of synthetic implant materials to promote bone repair in the rat tibial defect model. J Bone Miner Res 7: 255
3. Cornell CN, Lane JM (1992) Newest factors in fracture healing. Clin Orthop 277: 297-311
4. Csernok E, Szymkowiak CH, Mistry N, Kekow J (1996) Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Clin Exp Immunol 105: 104-111
5. Damien CJ, Parsons JR (1991) Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomaterials 2: 187-208
6. d'Hoedt B, Lindemann W, Huttemann H (1989) Materialkundliche Untersuchungen an Hydroxylapatitkeramiken unterschiedlicher Genese. Z Zahnarztl Implantol 5: 211-219
7. Downes S, Di Silvio L, Klein C, Kayser MV (1991) Growth-hormone loaded bioactive ceramics. J Mater Sci 2: 176-180
8. Gombotz WR, Pankey SC, Ranchalis J, Puolakkainen P (1993) Controlled release of TGF-beta 1 from a biodegradable matrix for bone regeneration. J Biomater Sci Polym 5: 49-63
9. Goodman GR, Dissanayake IR, Bowman AR, Epstein S (2001) Transforming growth factor beta administration modifies cyclosporine A-induced bone loss. Bone 28: 583-588
10. Jensen SS, Aaboe M, Hjørting-Hansen E, Ruyter IE (1996) Tissue reaction and material characteristics of four bone substitutes. Int J Oral Maxillofac Implants 11: 55-66
11. Kekow J, Gross WL (1992) Transforming growth factor beta: its mechanism of action and clinical significance. Dtsch Med Wochenschr 117: 228-235
12. Kekow J, Wachsman W, McCutchan JA, Cronin M, Lotz M (1990) Transforming growth factor beta and non-cytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc Natl Acad Sci 87: 8321-8325
13. Laffargue P, Fialdes P, Frayssinet P (2000) Adsorption and release of insulin-like growth factor-1 on porous tricalcium phosphate implant. J Biomed Mat Res 3: 415-421
14. LeGeros RZ, Bautista C, Styner D, Retino M, Valdecanas A (1995) Comparative properties of bioactive bone graft materials. Bioceramics 8: 81-87
15. Lind M, Schumacker B, Soballe K (1993) Transforming growth factor beta enhances fracture healing in rabbit tibiae. Acta Orthop Scand 64: 553-556
16. Lind M, Overgaard S, Ongpipattanakul B (1996) Transforming growth factor β1 stimulates bone ongrowth to weight-loaded tricalcium phosphate coated implants. An experimental study on dogs. J Bone Joint Surg [Br] 78: 377-382
17. Lotz M, Kekow J, Carson DA (1990) Transforming growth factor-beta and cellular immune responses in synovial fluids. J Immunol 144: 4189-4194
18. Mohan S, Jennings JC, Linkhart TA, Baylink DJ (1988) Primary structure of human skeletal growth factor: homology with human insulin-like growth factor II. Biochim Biophys Acta 966: 44-55
19. Pecina M, Giltaij LR, Vukicevic S (2001) Orthopaedic applications of osteogenic protein-1 (BMP-7). Int Orthop 25: 203-208
20. Ripamonti U, Crooks J, Matsaba T, Tasker J (2000) Induction of enchondral bone formation by recombinant human transforming growth factor-beta2 in the baboon (Papio ursinus). Growth Factors 17: 269-285
21. Roesgen M (1990) The regenerative ability of the iliac crest following spongiosa removal in man - Induction by phosphate ceramics? Unfallchirurgie 16: 258-265
22. Schmidtmaier G, Wildemann B, Stemberger A (2001) Biodegradable Poly(D,L-Lactide) Coating of implants for continuous release of growth factors. J Biomed Mater Res 58: 449-455
23. Summer DR, Turner TM, Purchio AF, Galante JO (1995) Enhancement of bone ingrowth by transforming growth factorbeta. J Bone Joint Surg [Am] 77: 1135-1147
24. Szymkowiak CH, Mons I, Gross WL, Kekow J (1995) Determination of transforming growth factor beta 2 in human blood samples by ELISA. J Immunol Methods 184: 263-271
25. Trippel SB, Coutts RD, Einhorn TA, Rosenfeld RG (1996) Growth factors as therapeutic agents. J Bone Joint Surg [Am] 78:1272-1286
26. Wang JS, Aspenberg P (1994) Basic fibroblast growth factor increases allograft incorporation. Bone chamber study in rats. Acta Orthop Scand 65: 27-31
27. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Wozney JM (1990) Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87: 2220-2224
28. Yasko AW, Lane JM, Fellinger EJ, Wozney JM, Wang EA (1992) The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg [Am] 74: 659-670